Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man (Q39372893)

11 September 2017

title

Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man. (English)

1 reference

11 September 2017

Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56589

9 April 2022

author name string

J. Rosenthal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56589

9 April 2022

S. Raptis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56589

9 April 2022

F. Escobar-Jimenez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56589

9 April 2022

E. F. Pfeiffer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56589

9 April 2022

language of work or name

English

0 references

publication date

1 April 1976

1 reference

11 September 2017

10 April 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=56589

full work available at URL

9 April 2022

https://api.elsevier.com/content/article/PII:S0140673676916111?httpAccept=text/xml

1 reference

10.1016/S0140-6736(76)91611-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91611-1

https://api.elsevier.com/content/article/PII:S0140673676916111?httpAccept=text/plain

9 April 2022

1 reference

10.1016/S0140-6736(76)91611-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91611-1

9 April 2022

1 reference

11 September 2017

volume

1

1 reference

11 September 2017

issue

7963

1 reference

11 September 2017

page(s)

772-774

1 reference

Inhibition of insulin secretion by somatostatin

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Glucagon control of fasting glucose in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effects of Somatostatin on Gastric Secretion and Gastrin Release in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Thyrotropin-releasing hormone stimulation and somatostatin inhibition of growth hormone secretion from perfused rat adenohypophyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effects of somatostatin on the secretion of thyrotropin and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Somatostatin: A potent inhibitor of ACTH-Hypersecretion in adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Immunoassay of Human Growth Hormone in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Effect of Secretin on Circulating Gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Dopamine Receptors in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Somatostatin-Induced Inhibition of Insulin Secretion from Isolated Islets of Rat Pancreas in Presence of Glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

Failure of somatostatin to correct manifest diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991611-1

7 January 2021

10.1016/S0140-6736(76)91611-1

Identifiers

DOI

1 reference

11 September 2017

1 reference